Overview
Linitis plastica is a rare, advanced form of sclerosing or infiltrative intra-abdominal fibrosis predominantly affecting the uterus and surrounding tissues, often seen in advanced cases of adenomyosis or endometriosis. This condition leads to a hardening and induration of the abdominal wall, mimicking an "inverted-suit" appearance due to the extensive fibrotic changes. It primarily impacts women of reproductive age, though it can occur at any age. The clinical significance lies in its potential to cause severe abdominal distension, pain, and complications such as bowel obstruction and infertility. Recognizing linitis plastica early is crucial for appropriate management and to prevent debilitating complications, making it essential for clinicians to be aware of its clinical presentation and diagnostic approach in day-to-day practice 12.Pathophysiology
Linitis plastica represents a severe progression of diffuse peritoneal and uterine fibrosis, often secondary to chronic inflammation or endometriosis. The underlying mechanism involves persistent inflammatory responses that stimulate fibroblasts to produce excessive collagen and other extracellular matrix proteins. This process leads to the progressive replacement of normal tissue with dense fibrous tissue, affecting not only the uterus but also the ovaries, fallopian tubes, and the abdominal wall. Molecularly, cytokines such as transforming growth factor-beta (TGF-β) play a pivotal role in promoting fibroblast activation and collagen synthesis, driving the fibrotic cascade 2. Over time, these changes result in the characteristic rigidity and induration observed clinically, impacting organ function and patient quality of life.Epidemiology
The incidence of linitis plastica is exceedingly rare, with limited epidemiological data available. It predominantly affects women, typically in their reproductive years, though cases have been reported across all ages. Geographic distribution does not appear to show significant variations, suggesting a consistent risk profile globally. Risk factors include a history of endometriosis or adenomyosis, though the exact triggers and predisposing factors remain incompletely understood. Trends over time indicate no substantial increase in reported cases, possibly due to its rarity and diagnostic challenges 2.Clinical Presentation
Patients with linitis plastica often present with a palpable, woody-hard abdomen resembling an "inverted-suit" appearance, alongside significant abdominal distension and discomfort. Common symptoms include chronic pelvic pain, dyspareunia (painful intercourse), and in advanced cases, bowel obstruction due to compression or adhesions. Atypical presentations might involve vague systemic symptoms like fatigue or weight loss, especially if there is significant involvement of other abdominal organs. Red-flag features include acute abdominal pain, signs of bowel obstruction, and unexplained significant weight loss, necessitating urgent evaluation to rule out life-threatening complications 2.Diagnosis
The diagnosis of linitis plastica involves a combination of clinical evaluation and imaging techniques. Clinically, the hallmark is the characteristic hardening of the abdominal wall and uterus. Diagnostic imaging, particularly MRI and ultrasound, plays a crucial role in confirming the extent of fibrotic changes and ruling out other conditions. Specific criteria for diagnosis include:Management
Management of linitis plastica is multifaceted, focusing on symptom relief, prevention of complications, and addressing underlying causes.First-Line Management
Second-Line Management
Refractory / Specialist Escalation
Complications
Common complications include:Referral to a specialist is warranted for managing refractory pain, surgical complications, or when considering advanced interventions to prevent further deterioration 2.
Prognosis & Follow-up
The prognosis for patients with linitis plastica varies widely depending on the extent of disease and complications. Prognostic indicators include the severity of symptoms, presence of bowel obstruction, and response to initial treatments. Regular follow-up is essential, typically every 3-6 months initially, focusing on symptom assessment, imaging to monitor disease progression, and management of complications. Long-term monitoring should include gynecological evaluations and nutritional support to address any functional impairments 2.Special Populations
Key Recommendations
References
1 Patel V, Deleonibus A, Wells MW, Bernard SL, Schwarz GS. Distinguishing Authentic Voices in the Age of ChatGPT: Comparing AI-Generated and Applicant-Written Personal Statements for Plastic Surgery Residency Application. Annals of plastic surgery 2023. link 2 Charlton-Howard HS, Bond AL, Rivers-Auty J, Lavers JL. 'Plasticosis': Characterising macro- and microplastic-associated fibrosis in seabird tissues. Journal of hazardous materials 2023. link 3 Durairaj KK, Devgan L, Lee Bs A, Khachatourian Bs N, Nguyen Bs V, Issa Bs T et al.. Poly-L-Lactic Acid for Gluteal Augmentation found to be Safe and Effective in Retrospective Clinical Review of 60 Patients. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2020. link 4 Zhang WJ, Ding W, Jiang H, Zhang YF, Zhang JL. National representation in the plastic and reconstructive surgery literature: a bibliometric analysis of highly cited journals. Annals of plastic surgery 2013. link 5 Jorissen M. Rhinoplasty: why do I not use morphing?. B-ENT 2010. link